Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus.

Hobson-Peters J, Harrison JJ, Watterson D, Hazlewood JE, Vet LJ, Newton ND, Warrilow D, Colmant AMG, Taylor C, Huang B, Piyasena TBH, Chow WK, Setoh YX, Tang B, Nakayama E, Yan K, Amarilla AA, Wheatley S, Moore PR, Finger M, Kurucz N, Modhiran N, Young PR, Khromykh AA, Bielefeldt-Ohmann H, Suhrbier A, Hall RA.

Sci Transl Med. 2019 Dec 11;11(522). pii: eaax7888. doi: 10.1126/scitranslmed.aax7888.

PMID:
31826984
2.

Chimeric viruses of the insect-specific flavivirus Palm Creek with structural proteins of vertebrate-infecting flaviviruses identify barriers to replication of insect-specific flaviviruses in vertebrate cells.

Piyasena TBH, Newton ND, Hobson-Peters J, Vet LJ, Setoh YX, Bielefeldt-Ohmann H, Khromykh AA, Hall RA.

J Gen Virol. 2019 Nov;100(11):1580-1586. doi: 10.1099/jgv.0.001326.

PMID:
31524580
3.

Flaviviruses and flavivirus vaccines.

Heinz FX, Stiasny K.

Vaccine. 2012 Jun 19;30(29):4301-6. doi: 10.1016/j.vaccine.2011.09.114. Review.

PMID:
22682286
4.

Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.

Erasmus JH, Seymour RL, Kaelber JT, Kim DY, Leal G, Sherman MB, Frolov I, Chiu W, Weaver SC, Nasar F.

J Virol. 2018 Jan 30;92(4). pii: e01274-17. doi: 10.1128/JVI.01274-17. Print 2018 Feb 15.

5.
6.

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.

Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J.

Vaccine. 2010 Jan 8;28(3):632-49. doi: 10.1016/j.vaccine.2009.09.098. Epub 2009 Oct 4. Review.

PMID:
19808029
7.

Identifying Attenuating Mutations: Tools for a New Vaccine Design against Flaviviruses.

Khou C, Pardigon N.

Intervirology. 2017;60(1-2):8-18. doi: 10.1159/000479966. Epub 2017 Sep 5. Review.

8.

Structural gene (prME) chimeras of St Louis encephalitis virus and West Nile virus exhibit altered in vitro cytopathic and growth phenotypes.

Maharaj PD, Anishchenko M, Langevin SA, Fang Y, Reisen WK, Brault AC.

J Gen Virol. 2012 Jan;93(Pt 1):39-49. doi: 10.1099/vir.0.033159-0. Epub 2011 Sep 21.

9.

Insect-specific flaviviruses, a worldwide widespread group of viruses only detected in insects.

Calzolari M, Zé-Zé L, Vázquez A, Sánchez Seco MP, Amaro F, Dottori M.

Infect Genet Evol. 2016 Jun;40:381-388. doi: 10.1016/j.meegid.2015.07.032. Epub 2015 Jul 31.

PMID:
26235844
10.

Live flavivirus vaccines: reasons for caution.

Seligman SJ, Gould EA.

Lancet. 2004 Jun 19;363(9426):2073-5. Review.

PMID:
15207960
11.

Current status of flavivirus vaccines.

Barrett AD.

Ann N Y Acad Sci. 2001 Dec;951:262-71. Review.

PMID:
11797783
12.
13.

Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.

Tsouchnikas G, Zlatkovic J, Jarmer J, Strauß J, Vratskikh O, Kundi M, Stiasny K, Heinz FX.

J Virol. 2015 Aug;89(15):7970-8. doi: 10.1128/JVI.00938-15. Epub 2015 May 27.

14.

An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.

Urakami A, Ngwe Tun MM, Moi ML, Sakurai A, Ishikawa M, Kuno S, Ueno R, Morita K, Akahata W.

J Virol. 2017 Nov 14;91(23). pii: e01181-17. doi: 10.1128/JVI.01181-17. Print 2017 Dec 1.

15.

A new insect-specific flavivirus from northern Australia suppresses replication of West Nile virus and Murray Valley encephalitis virus in co-infected mosquito cells.

Hobson-Peters J, Yam AW, Lu JW, Setoh YX, May FJ, Kurucz N, Walsh S, Prow NA, Davis SS, Weir R, Melville L, Hunt N, Webb RI, Blitvich BJ, Whelan P, Hall RA.

PLoS One. 2013;8(2):e56534. doi: 10.1371/journal.pone.0056534. Epub 2013 Feb 27.

16.

West Nile virus vaccine.

Monath TP, Arroyo J, Miller C, Guirakhoo F.

Curr Drug Targets Infect Disord. 2001 May;1(1):37-50. Review.

PMID:
12455232
17.

High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon.

Matsuda M, Yamanaka A, Yato K, Yoshii K, Watashi K, Aizaki H, Konishi E, Takasaki T, Kato T, Muramatsu M, Wakita T, Suzuki R.

Sci Rep. 2018 Nov 9;8(1):16624. doi: 10.1038/s41598-018-34865-y.

18.

Serological evidence of Flavivirus circulation in human populations in Northern Kenya: an assessment of disease risk 2016-2017.

Chepkorir E, Tchouassi DP, Konongoi SL, Lutomiah J, Tigoi C, Irura Z, Eyase F, Venter M, Sang R.

Virol J. 2019 May 17;16(1):65. doi: 10.1186/s12985-019-1176-y.

19.

Noncoding Subgenomic Flavivirus RNA Is Processed by the Mosquito RNA Interference Machinery and Determines West Nile Virus Transmission by Culex pipiens Mosquitoes.

Göertz GP, Fros JJ, Miesen P, Vogels CBF, van der Bent ML, Geertsema C, Koenraadt CJM, van Rij RP, van Oers MM, Pijlman GP.

J Virol. 2016 Oct 28;90(22):10145-10159. doi: 10.1128/JVI.00930-16. Print 2016 Nov 15.

20.

Base Distribution in Dengue Nucleotide Sequences Differs Significantly from Other Mosquito-Borne Human-Infecting Flavivirus Members.

Roy P, Dey S, Nandy A, Basak SC, Das S.

Curr Comput Aided Drug Des. 2019;15(1):29-44. doi: 10.2174/1573409914666180731090005.

PMID:
30062973

Supplemental Content

Support Center